Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.4 USD | +0.19% | +2.76% | +19.59% |
11:00am | BioMed X Announces the Start of A New Research Project in Partnership with Merck | CI |
29/04 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.59% | 330B | |
+32.72% | 664B | |
+29.29% | 567B | |
-7.13% | 354B | |
+4.87% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.99% | 148B | |
-10.72% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck : SVB Leerink Adjusts Merck & Co.'s Price Target to $99 from $102, Keeps Outperform Rating